The Fibromyalgia and Sleep Disorders Scientific Conference<
Sponsored by
The National Fibromyalgia Research Association (NFRA)
Thursday October 2 - Saturday, October 4, 2008
The Downtown Portland Waterfront Marriott, Portland, Oregon
The National Fibromyalgia Research Association (NFRA) is committed to developing timely and relevant education for healthcare providers treating fibromyalgia syndrome (FMS). Despite recent media attention, FMS remains underdiagnosed and undertreated, with no standard management strategy in place.
More than 75% of fibromyalgia patients complain of sleep disturbances and fatigue. Current research suggests that nearly 50% of FMS patients suffer with intrusive alpha wave periods. Other research repots on the frequency of obstructive sleep apnea, upper airway resistance syndrome, insomnia, restless legs syndrome (RLS), and periodic limb movement syndrome (PLMS). These comorbidities increase the symptoms of pain and fatigue, negatively impacting quality of life.
Join your colleagues for this ground-breaking conference where the science of sleep is examined in relation to FMS and selected movement disorders. |
After attending this conference, participants will be able to:
- Describe the syndromes, epidemiology, and pathogenesis of fibromyalgia
- Apply the principles of rational therapeutic selection to fibromyalgia-related pain
- Implement evidence-based best practices and clinical strategies for fibromyalgia
- Evaluate the relationship between fibromyalgia and insomnia
- Explain the impact of aging on the sleep/wake cycle
- Discuss common neurochemical pathways mediating the experience of pain and insomnia and describe treatment options based upon them
- Identify key aspects in history-taking to assess pain's impact on sleep, and integrate insomnia management into the treatment of pain
Target Audience:
- Primary care physicians
- Rheumatologists
- Sleep Specialists
- Register NOW!
| CONFERENCE AGENDA |
Information about schedule, speakers and presentation titles. |
| CALL FOR POSTERS |
Call for Clinical and Scientific Abstracts : To enrich attendee experience, we are offering an opportunity to share the latest information garnered from current research and clinical findings with practitioners who are on the frontline in the treatment of fibromyalgia, myofascial pain and sleep disorders. |
| EXHIBITOR INFORMATION |
Exhibits will provide the opportunity for attendees to interact directly with vendors regarding services and products related to fibromyalgia, sleep and general needs of medical professionals. All buffets and breaks will be in the Exhibit Hall. The Hall is not open during plenary sessions. |
Hotel: Portland Downtown Waterfront Marriott. $179/night plus tax. Rate guaranteed for Wed-Sat night, October 1-4. Call reservations directly at 800-546-9513 and ask for the fibromyalgia room block and rate.
If you would like to learn more about Portland, Oregon visit TravelPortland.com, the Portland, Oregon Visitors Association website.
|
FDA APPROVES CYMBALTA (DULOXETINE) FOR THE MANAGEMENT OF FIBROMYALGIA
more details |
|
